HOME >> MEDICINE >> NEWS
Political commitment and strong health systems needed to control tropical worm disease

Many middle-income countries have made great progress in the control of the tropical worm disease schistosomiasis, but political commitment and strong health systems are now needed to help countries with fewer resources, state the authors of a Seminar in this week's issue of the Lancet.

Schistosomiasis is a wide-spread parasitic disease caused by infection with flatworms. The disease mainly affects people living in tropical countries that come into contact with infested waters but it can also affect travelers. Up to 200 million people are estimated to be infected worldwide. Dependent of the species of worm and stage of disease, symptoms may include diarrhoea, liver damage and portal hypertension, or bloody urine, and bladder/kidney damage.

Wide-scale drug treatment combined with socio-economic progress has greatly reduced the impact of schistosomiasis in middle-income countries such as Egypt, China, Brazil, the Philippines and Morocco. However, low-income countries, especially those in sub-Saharan Africa, have had greater difficulties in implementing and sustaining drug-based control strategies. Early pilot projects in countries such as Mali and Madagascar showed promising early results but floundered when foreign assistance ended.

Author Professor Bruno Gryseels states: "The fight against schistosomiasis is not just a matter of distributing drugs; establishment of strong health systems that are able to take care of patients and to integrate sustainable control measures is a far greater and more important challenge."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
21-Sep-2006


Page: 1

Related medicine news :

1. Political party policies to reduce social inequalities have better health outcomes
2. Political prejudice preventing progress on prison health
3. New AIDS Tech Transfers reinforce Roche commitment to strengthen African manufacturing
4. Rockefeller Foundation will not abandon its commitments to public health
5. AAMRI welcomes Canberras fresh commitment to medical research funding
6. Autism Speaks makes major funding commitment for unprecedented national autism database
7. Americans think commitment to health research should be stronger
8. Eight million dollar commitment to schizophrenia research
9. Smoking may strongly increase long-term risk of eye disease
10. Novel candidate biomarker for heart failure also strongly predicts risk of death
11. Nancy Brinker and Lance Armstrong honored with Centennial Medals at the AACR 2007 Annual Meeting

Post Your Comments:
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted an ... details the development of RT001, a form of topical botulinum ... trials. For those afraid of needles, the idea of a ... if the drug ultimately gets FDA approval it will be ... , “As the article notes, the size of the ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 The winter ... mold growth and expansion. When mold grows, it can be ... be sure to avoid the consequences of mold growth with ... Long Island, is offering tips on the best ways to ... wet season, which makes perfect conditions for mold to thrive. ...
(Date:2/27/2015)... Vancouver, BC (PRWEB) February 27, 2015 ... exciting overnight deals for couples who wanted to spend ... with the opportunity to get a jump on Valentine’s ... meal and stay in one of their luxurious rooms. ... on February 13, inviting guests for a mouthwatering 3 ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being ... Gold Plus hospital. In order to receive the award, ... to all Get With The Guidelines - Stroke Quality ... and achieved 75-percent or higher compliance with six of ... These are reporting initiatives to measure quality of care. ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2
(Date:2/27/2015)... Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the fourth quarter and full ... was a transformative year for PTC. We are now ... developing RNA-targeted therapies in the rare disease space," stated ... Inc. "We are proud to bring the first treatment ...
(Date:2/27/2015)... 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... it acquired Bionik Laboratories, Inc., a Toronto ... to qualified accredited investors of units consisting of its ... approximately $6.2 million. Shares of the Company,s common stock ... under the symbol "DWTPD" until FINRA,s approval of the ...
(Date:2/26/2015)... -- RnRMarketResearch.com adds Corneal Ulcers - ... its store. This report p provides an overview ... The report "Corneal Ulcers - Pipeline Review, H2 2014" provides ... Ulcers. Corneal Ulcers are primarily result of the ... & fungal infections. The symptoms of the corneal ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
Cached News: